RxDoctor Payments Data

Stella Heredia, MD

General Practice · Clermont, FLNPI 1902475288

Payments from drug & device makers

$526in general payments, 2019–2025

Across 25 payments — averaging $21.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$261
  • Exact Sciences$66
  • Lilly USA, LLC$36
  • BD$34
  • Abiomed$32
  • Pfizer$28
  • plus $68 from 4 others

What the payments were for

  • Food & beverage$526100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$526 in reported general payments places this provider in the 65th percentile of 6,901 general practice providers in Florida.

See all general practice providers in Florida

Medicare billing

Part B allowed, 2024
$24,095
Medicare patients
57
Services billed
347

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin92$103,627
TrulicityDulaglutide51$51,269
OzempicSemaglutide41$44,674
EliquisApixaban36$34,587
MounjaroTirzepatide11$12,907
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$12,125
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog12$9,566
Lantus SolostarInsulin Glargine,hum.Rec.Anlog40$4,575
SymbicortBudesonide/Formoterol Fumarate12$3,031
Albuterol Sulfate HfaAlbuterol Sulfate65$1,743
Atorvastatin Calcium255$1,713
Gabapentin154$1,537
Famotidine159$1,428
Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort24$1,326
Levothyroxine Sodium139$1,315

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$17$103,62792 claims
Lilly USA, LLCTrulicity, Mounjaro$36$64,17662 claims
Novo NordiskOzempic$261$44,67441 claims
PfizerEliquis$28$34,58736 claims
GSKTrelegy Ellipta$17$12,12517 claims
AstraZenecaSymbicort$17$3,03112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 6,901 general practice providers in Florida.

Other general practice in Clermont

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →